A similar mechanism could play a central role in peripherally-induced dystonia, and future studies should investigate the role of PIEZO2 overexpression in patients with peripherally-induced dystonia and the putative role of early botulinum toxin injection. The gene discussed is PIEZO2; the disease is Dystonia.